In spite of the expansion of women's roles over the last 20 years, ads for
psychotropic drugs in scientific journals often persist in portraying women in
traditional settings and roles.
A study that led to this finding was conducted by Donna Stewart, M.D.,
chair of women's health at University Health Network and the University of
Toronto in Canada, and colleagues. Results appeared in the April Journal
of Nervous and Mental Disease.
In their study, Stewart and her colleagues examined how often women and men
were portrayed in psychotropic drug ads placed in three psychiatric journals
during three different time periods. The journals were the American
Journal of Psychiatry, Canadian Journal of Psychiatry, and British
Journal of Psychiatry. The study periods were 1981, 1991, and 2001.
The proportion of women and men displayed in ads in all three journals in
1981 was about equal, the researchers found. However, the proportion of women
had increased to 80 percent in the Canadian Journal of Psychiatry in
2001 and to 88 percent in the American Journal of Psychiatry in 2001.
In contrast, the proportion of women portrayed in the British Journal of
Psychiatry in 2001 had declined to 40 percent.
Trying to impart meaning to the findings, the researchers noted that given
that women are known to be more at risk of depression than men, one
possibility is that more antidepressant ads are run in these two journals
today than in the earlier years and that women are depicted in the ads more
often because they are more likely to seek treatment for depression. In fact,
the researchers learned, only women were displayed in antidepressant ads in
the American Journal of Psychiatry in 2001. But another reason why
women appear in more psychotropic drug ads in the Canadian Journal of
Psychiatry and the American Journal of Psychiatry today, the
researchers suspected, may be a form of gender discrimination against
women.FIG1
In fact, when the researchers examined the types of roles in which women
and men were cast in the ads in the three journals across the three time spans
studied, they found that most of the men were portrayed at work or in
professional roles, implying productivity, independence, and a higher
socioeconomic status, while most of the women were shown at home, in the
garden, in a social situation, or asleep, implying traditional and dependent
work roles.
"These findings," the investigators suggested, "seem to
indicate that, despite the great diversification and expansion of women's
roles over the last 20 years, there is a consistent tendency in pharmaceutical
advertising to represent women submissively (i.e., sleeping) or even in a
sexualized manner (i.e., well-dressed, slim, younger, attractive) in
traditional settings and roles...."
Stewart told Psychiatric News that she hoped clinical
psychiatrists will "look beyond the images in pharmaceutical
advertisements, which may not accurately reflect the images of many patients
suffering from depression or psychosis—multicultural patients, men, the
poor, the elderly, the disabled, and the physically unglamorous."
An abstract of the study, "Who Is Portrayed in Psychotropic
Drug Advertisements?," can be accessed online at<www.jonmd.com>
by clicking on the April issue and then the article title. ▪